The results showed that pleural fluid CEA was an independent predictor of EGFR mutation in patients with lung adenocarcinoma with MPE (OR: 1.024, 95% CI: 1.011–1.037, P < 0.001) (Table 5). The gene discussed is CEACAM5; the disease is lung adenocarcinoma.